Abu Dhabi leads transformative health sciences mission to China, forging partnerships in innovation and clinical excellence
The Department of Health – Abu Dhabi has concluded a landmark delegation visit to leading Chinese healthcare institutions, establishing collaborative pathways across artificial intelligence, precision medicine and advanced therapeutics that promise to accelerate innovation and improve health outcomes across the region and beyond.
The Department of Health – Abu Dhabi has concluded its inaugural health and life sciences mission to China, a strategic engagement designed to advance collaboration in areas of profound consequence to modern healthcare. Through thirty-two meetings and site visits across Shanghai, Shenzhen and Beijing, Abu Dhabi’s thriving health and life sciences ecosystem connected with leading Chinese healthcare institutions, universities and innovators to explore pathways for translating scientific and technological advancement into measurable improvements in patient outcomes.
The mission transcended conventional technology exchange, instead identifying substantive opportunities to unite China’s formidable scientific, technological and manufacturing capabilities with Abu Dhabi’s distinguished integrated healthcare ecosystem, its comprehensive population-scale data and genomic resources, advanced clinical infrastructure and particularly its agile regulatory environment. Discussions examined joint research and clinical studies, technology validation and adoption, knowledge transfer and manufacturing partnerships, alongside opportunities to develop and scale innovative solutions from Abu Dhabi to regional and international markets.
Precision Medicine and Advanced Therapeutics
Engagements with leading biotechnology and pharmaceutical companies explored opportunities to accelerate the development and accessibility of next-generation treatments. Discussions spanning advanced cell therapies, biologics, drug discovery and organoid-based research examined pathways for clinical research, evidence generation and knowledge transfer. The mission particularly emphasised how Abu Dhabi’s diverse patient population, genomic capabilities and clinical research environment could support the validation of therapies across different populations, thereby shortening the pathway from scientific discovery to patient access.
Artificial Intelligence and Healthcare Innovation
Across engagements spanning AI-native hospitals, surgical robotics, laboratory automation, advanced imaging and brain-computer interfaces, discussions identified potential pathways for clinical evaluation, joint development, specialised training and responsible technology adoption. A particular focus emerged on advancing beyond individual AI applications towards integrated healthcare intelligence that spans the complete patient journey, alongside exploring how advanced surgical and diagnostic technologies could be validated within Abu Dhabi’s clinical environment and potentially scaled internationally.
Precision Oncology and Genomic Advancement
Precision oncology represented a major focal point, with engagements exploring how advanced molecular diagnostics, imaging, genomics and artificial intelligence could fundamentally transform the cancer pathway from earlier screening and diagnosis through treatment selection and recurrence monitoring. Discussions considered how Chinese diagnostic innovation could connect with Abu Dhabi’s genomic, health-data and clinical research infrastructure to validate emerging technologies across diverse populations, generate new evidence and accelerate their integration into clinical practice.
Building on Abu Dhabi’s existing genomics and biobanking capabilities, the delegation explored opportunities to connect population-scale biological data with advanced multi-omics and AI research capabilities. Potential areas of collaboration include deepening understanding of diseases affecting local populations, supporting earlier identification of health risks, shortening diagnostic journeys for rare diseases and accelerating the development of more precise diagnostics, treatments and prevention strategies.
Translating Opportunity into Partnership
Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, observed that shaping the future of healthcare requires health ecosystems to connect scientific discovery and evidence with effective implementation and access to care. “Innovation alone cannot transform healthcare,” she stated. “China brings exceptional scientific, technological and manufacturing capabilities, while Abu Dhabi offers an integrated environment where innovation can be advanced, validated, applied and responsibly scaled. Through this mission, we have identified clear opportunities to combine these strengths across artificial intelligence, precision medicine, advanced therapies and diagnostics.”
The relationships established through the mission will continue through the Abu Dhabi Future Health Summit 2026, taking place from 20 to 22 October, with twenty-four organisations invited to participate. The summit will provide an immediate platform to progress discussions from exploration towards tangible research, clinical, investment and innovation partnerships.
The mission, led by the Department of Health – Abu Dhabi, brought together representatives from across the emirate’s health and life sciences ecosystem, including Cleveland Clinic Abu Dhabi, PureHealth, Abu Dhabi Investment Office, Mohamed bin Zayed University of Artificial Intelligence and L’IMAD, alongside DoH leadership and technical experts.
Source: Department of Health – Abu Dhabi Media Office, mediaoffice.abudhabi